These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27289340)

  • 21. Novel IL31RA gene mutation and ancestral OSMR mutant allele in familial primary cutaneous amyloidosis.
    Lin MW; Lee DD; Liu TT; Lin YF; Chen SY; Huang CC; Weng HY; Liu YF; Tanaka A; Arita K; Lai-Cheong J; Palisson F; Chang YT; Wong CK; Matsuura I; McGrath JA; Tsai SF
    Eur J Hum Genet; 2010 Jan; 18(1):26-32. PubMed ID: 19690585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel missense mutation in oncostatin M receptor beta causing primary localized cutaneous amyloidosis.
    Saeedi M; Ebrahim-Habibi A; Haghighi A; Zarrabi F; Amoli MM; Robati RM
    Biomed Res Int; 2014; 2014():653724. PubMed ID: 25054142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MCP-1 as an effector of IL-31 signaling in familial primary cutaneous amyloidosis.
    Shiao YM; Chung HJ; Chen CC; Chiang KN; Chang YT; Lee DD; Lin MW; Tsai SF; Matsuura I
    J Invest Dermatol; 2013 May; 133(5):1375-8. PubMed ID: 23303452
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunohistochemical study of immunoglobulin light chains and inflammatory cells in a patient with localized primary cutaneous nodular amyloidosis.
    Cai YX; Li SJ; Zhou Y; Li W; Fan YM
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):469-70. PubMed ID: 25399683
    [No Abstract]   [Full Text] [Related]  

  • 25. AHNAK, regulated by the OSM/OSMR signaling, involved in the development of primary localized cutaneous amyloidosis.
    Liu H; Qiu B; Yang H; Zheng W; Luo Y; Zhong Y; Lu P; Chen J; Luo Y; Liu J; Yang B
    J Dermatol Sci; 2023 May; 110(2):53-60. PubMed ID: 37100691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic analysis shows that the main constituent of subepidermal localised cutaneous amyloidosis is not galectin-7.
    Chapman JR; Liu A; Yi SS; Hernandez E; Ritorto MS; Jungbluth AA; Pulitzer M; Dogan A
    Amyloid; 2021 Mar; 28(1):35-41. PubMed ID: 32867548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three novel mutations in GPNMB in two pedigrees with amyloidosis cutis dyschromica.
    Wang J; Li Y; Xing L; Zhao M; Zhang S; Li Z; Yao Z; Li M
    Br J Dermatol; 2019 Dec; 181(6):1327-1329. PubMed ID: 31260093
    [No Abstract]   [Full Text] [Related]  

  • 28. Whole-exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling-Degos disease.
    Kono M; Sugiura K; Suganuma M; Hayashi M; Takama H; Suzuki T; Matsunaga K; Tomita Y; Akiyama M
    Hum Mol Genet; 2013 Sep; 22(17):3524-33. PubMed ID: 23666529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two missense mutations in GPNMB cause autosomal recessive amyloidosis cutis dyschromica in the consanguineous pakistani families.
    Rahman OU; Kim J; Mahon C; Jelani M; Kang C
    Genes Genomics; 2021 May; 43(5):471-478. PubMed ID: 33687658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary Localized Cutaneous Amyloidosis Affecting Female Individuals of a Pakistani Pedigree.
    Bhoyrul B; Ng A; Laws PM; Mathew B; Shanmugam S
    Am J Dermatopathol; 2019 May; 41(5):382-385. PubMed ID: 30308545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans.
    Yang CF; Lin SP; Chiang CP; Wu YH; H'ng WS; Chang CP; Chen YT; Wu JY
    Am J Hum Genet; 2018 Feb; 102(2):219-232. PubMed ID: 29336782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hereditary and non-hereditary cutaneous amyloidoses].
    Schreml S; Schroeder J; Eder F; Szeimies RM; Landthaler M; Babilas P
    Pathologe; 2009 May; 30(3):197-204. PubMed ID: 19319536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular basis and inheritance patterns of amyloidosis cutis dyschromica.
    Chiu FPC; Wessagowit V; Cakmak MF; Doolan BJ; Kootiratrakarn T; Chaowalit P; Bunnag T; Simpson MA; McGrath JA; Onoufriadis A
    Clin Exp Dermatol; 2020 Jul; 45(5):650-653. PubMed ID: 32097499
    [No Abstract]   [Full Text] [Related]  

  • 34. Image Gallery: Cutaneous findings in an adult with X-linked reticulate pigmentary disorder.
    Xu Z; Lin Z
    Br J Dermatol; 2019 Feb; 180(2):e37. PubMed ID: 30714101
    [No Abstract]   [Full Text] [Related]  

  • 35. Familial primary localized cutaneous amyloidosis in Brazil.
    Sakuma TH; Hans-Filho G; Arita K; Odashiro M; Odashiro DN; Hans NR; Hans-Neto G; McGrath JA
    Arch Dermatol; 2009 Jun; 145(6):695-9. PubMed ID: 19528426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial primary cutaneous amyloidosis: Caspase activation may be involved in amyloid formation.
    Antoñanzas J; Pelacho-Samper B; Alkorta-Aranburu G; Echeveste JI; Alonso AE
    Exp Dermatol; 2022 Oct; 31(10):1638-1640. PubMed ID: 35790029
    [No Abstract]   [Full Text] [Related]  

  • 37. Cutaneous amyloidoses: a minimum common denominator in their amino acid sequence.
    Guarneri F; Cannavò SP; Benvenga S
    Comput Biol Med; 2014 Jul; 50():14-8. PubMed ID: 24813680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A homozygous Y131X GPNMB mutation in a Chinese family with amyloidosis cutis dyschromica.
    Wang X; Sun J
    Int J Dermatol; 2022 Apr; 61(4):e118-e120. PubMed ID: 34628647
    [No Abstract]   [Full Text] [Related]  

  • 39. [Amyloid lichen (type Freudenthal) or primary localized cutaneous amyloidosis (type Gutmann)].
    DE GRACIANSKY P; GRUPPER C
    Bull Soc Fr Dermatol Syphiligr; 1955; (5):497-8. PubMed ID: 13316364
    [No Abstract]   [Full Text] [Related]  

  • 40. [Primary cutaneous amyloidosis (amyloid lichen)].
    de GRACIANSKY P; BOULLE S; CECCALDI PF; LECLERCQ R; BOUJNAH A
    Bull Soc Fr Dermatol Syphiligr; 1950 Jul; 57(4):393-5. PubMed ID: 14801630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.